FMR CORP 13D and 13G filings for Tenaya Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 12:39 pm Sale |
2023-02-09 | 13G | Tenaya Therapeutics, Inc. TNYA |
FMR CORP | 2,830,476 4.236% |
-294,822 (-9.43%) |
Filing |
| 2022-10-11 09:03 am Sale |
2022-10-07 | 13G | Tenaya Therapeutics, Inc. TNYA |
FMR CORP | 3,125,298 7.555% |
-2,598,434 (-45.40%) |
Filing |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Tenaya Therapeutics, Inc. TNYA |
FMR CORP | 5,723,732 13.865% |
1,165,987 (+25.58%) |
Filing |
| 2021-08-10 10:33 am Purchase |
2021-08-09 | 13G | Tenaya Therapeutics, Inc. TNYA |
FMR CORP | 4,557,745 11.590% |
4,557,745 (New Position) |
Filing |